Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Oliver Heidmann Pedersen"'
Autor:
Mads Lamm Larsen, Oliver Heidmann Pedersen, Anne-Mette Hvas, Peter Buur van Kooten Niekerk, Søren Bønløkke, Steen Dalby Kristensen, Erik Lerkevang Grove
Publikováno v:
Platelets, Vol 30, Iss 3, Pp 322-328 (2019)
Insufficient platelet inhibition has been reported in up to 40% of aspirin-treated patients, including patients with essential thrombocytosis. To maintain sufficient platelet inhibition, a shorter dosing interval with aspirin has been suggested. We a
Externí odkaz:
https://doaj.org/article/b3da491241fd443f99f4c33d13fc8cbb
Publikováno v:
Platelets, Vol 29, Iss 2, Pp 199-202 (2018)
Flow cytometry is an increasingly used method for platelet function analysis because it has some important advantages compared with other platelet function tests. Flow cytometric platelet function analyses only require a small sample volume (3.5 mL);
Externí odkaz:
https://doaj.org/article/a8efa4e0d05045d19c0ed553438654d2
Autor:
Peter H. Nissen, Jenny Q D Tran, Erik Lerkevang Grove, Oliver Heidmann Pedersen, Anne-Mette Hvas, Mads Lamm Larsen, Steen Dalby Kristensen
Publikováno v:
Tran, J Q D, Pedersen, O H, Larsen, M L, Grove, E L, Kristensen, S D, Hvas, A-M & Nissen, P H 2020, ' Platelet microRNA expression and association with platelet maturity and function in patients with essential thrombocythemia ', Platelets, vol. 31, no. 3, pp. 365-372 . https://doi.org/10.1080/09537104.2019.1636019
Essential thrombocythemia (ET) is characterized by persistently elevated platelet counts and an increased risk of thromboembolic events. Dysregulated expression of small noncoding microRNAs (miRNAs) have been shown in ET and may influence platelet ma
Autor:
Mads Lamm Larsen, Steen Dalby Kristensen, Anne-Mette Hvas, Erik Lerkevang Grove, Søren Bønløkke, Peter Buur van Kooten Niekerk, Oliver Heidmann Pedersen
Publikováno v:
Larsen, M L, Pedersen, O H, Hvas, A-M, Niekerk, P B V K, Bønløkke, S, Kristensen, S D & Grove, E L 2019, ' Once-versus twice-daily aspirin treatment in patients with essential thrombocytosis ', Platelets, vol. 30, no. 3, pp. 322-328 . https://doi.org/10.1080/09537104.2018.1430356
Insufficient platelet inhibition has been reported in up to 40% of aspirin-treated patients, including patients with essential thrombocytosis. To maintain sufficient platelet inhibition, a shorter dosing interval with aspirin has been suggested. We a
Autor:
Anne-Mette Hvas, Peter Buur van Kooten Niekerk, Peter H. Nissen, Mads Lamm Larsen, Oliver Heidmann Pedersen, Steen Dalby Kristensen, Erik Lerkevang Grove, Søren Bønløkke
Publikováno v:
Pedersen, O H, Larsen, M L, Grove, E L, van Kooten Niekerk, P B, Bønløkke, S, Nissen, P H, Kristensen, S D & Hvas, A-M 2018, ' Platelet Characteristics in Patients with Essential Thrombocytosis ', Cytometry. Part B: Clinical Cytometry, vol. 94, no. 6, pp. 918-927 . https://doi.org/10.1002/cyto.b.21642
BACKGROUND: Essential thrombocytosis (ET) is a myeloproliferative disorder characterized by an increased platelet count. ET is associated with an increased risk of thrombosis, and procoagulant features of the disease may include an increased number o
Autor:
Erik Lerkevang Grove, Anne-Mette Hvas, Mads Lamm Larsen, Steen Dalby Kristensen, Oliver Heidmann Pedersen
Publikováno v:
Pedersen, O H, Larsen, M L, Kristensen, S D, Hvas, A-M & Grove, E L 2017, ' Recurrent Cardiovascular Events Despite Antiplatelet Therapy in a Patient with Polycythemia Vera and Accelerated Platelet Turnover ', American Journal of Case Reports, vol. 18, pp. 945-948 . https://doi.org/10.12659/AJCR.904148
The American Journal of Case Reports
The American Journal of Case Reports
Patient: Male, 58 Final Diagnosis: STEMI Symptoms: Angina pectoris Medication:— Clinical Procedure: — Specialty: Hematology Objective: Unusual clinical course Background: Clopidogrel is commonly used in the prevention and treatment of cardiovascu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e757cddb93c86e5454b11e65961de96c
https://pure.au.dk/portal/da/publications/recurrent-cardiovascular-events-despite-antiplatelet-therapy-in-a-patient-with-polycythemia-vera-and-accelerated-platelet-turnover(89d7edf5-1b9a-4565-94e5-e0a8d44bb1f0).html
https://pure.au.dk/portal/da/publications/recurrent-cardiovascular-events-despite-antiplatelet-therapy-in-a-patient-with-polycythemia-vera-and-accelerated-platelet-turnover(89d7edf5-1b9a-4565-94e5-e0a8d44bb1f0).html